Myovant Sciences Ltd.
MYOV
MYOV was delisted on the 9th of March, 2023.
98 hedge funds and large institutions have $548M invested in Myovant Sciences Ltd. in 2022 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 27 increasing their positions, 24 reducing their positions, and 22 closing their positions.
48% more capital invested
Capital invested by funds: $369M → $548M (+$178M)
32% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 22
13% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 24
8% more funds holding
Funds holding: 91 → 98 (+7)
27% less call options, than puts
Call options by funds: $9.92M | Put options by funds: $13.5M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$39.3M |
| 2 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
+$31.1M |
| 3 |
Invesco
Atlanta,
Georgia
|
+$3.23M |
| 4 |
Voloridge Investment Management
Jupiter,
Florida
|
+$2.06M |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$15.2M |
| 2 |
Marshall Wace
London,
United Kingdom
|
-$9.54M |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
-$5.19M |
| 4 |
Millennium Management
New York
|
-$4.02M |
| 5 |
RPAM
Rhenman & Partners Asset Management
Stockholm,
Sweden
|
-$3.85M |
MYOV Hedge Fund Activity: Q3 2022 in Review
98 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Myovant Sciences Ltd. (MYOV) for Q3 2022, worth a combined $548M — up 48% from $369M a quarter earlier.
Buyers outnumbered sellers: 29 funds opened new MYOV positions and 22 closed out — a net gain of 7 holders — while 27 added to existing stakes and 24 trimmed.
The largest buyer was Janus Henderson Group, adding an estimated $39.3M. The largest seller was Wellington Management Group, cutting an estimated $15.2M.
- 98 institutional investors held Myovant Sciences Ltd. (MYOV) as of Q3 2022, up from 91 in Q2 2022.
- Funds reported $548M of Myovant Sciences Ltd. stock for Q3 2022, up 48% quarter-over-quarter.
- 29 funds opened new Myovant Sciences Ltd. positions in Q3 2022 and 22 closed out, a net change of +7 holders.
- The largest Myovant Sciences Ltd. buyer in Q3 2022 was Janus Henderson Group, an estimated $39.3M added.
- The largest Myovant Sciences Ltd. seller in Q3 2022 was Wellington Management Group, an estimated $15.2M sold.
Based on aggregated 13F filings for Q3 2022.